Statements (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
gptkb:disease |
| gptkbp:affects |
gptkb:ureter
urethra bladder urinary tract renal pelvis |
| gptkbp:describedBy |
gptkb:Robbins_and_Cotran_Pathologic_Basis_of_Disease
gptkb:World_Health_Organization_Classification_of_Tumours |
| gptkbp:diagnosedBy |
biopsy
cystoscopy urine cytology |
| https://www.w3.org/2000/01/rdf-schema#label |
urothelial carcinoma
|
| gptkbp:ICD-10_code |
gptkb:C67
|
| gptkbp:isTreatedAt |
oncology department
urology department |
| gptkbp:mortalityRate |
higher in muscle invasive cases
|
| gptkbp:predecessor |
carcinoma in situ
urothelial dysplasia |
| gptkbp:prevalence |
increases with age
more common in males |
| gptkbp:prognosis |
depends on stage and grade
|
| gptkbp:recurrence |
high in non-muscle invasive cases
|
| gptkbp:riskFactor |
smoking
chronic bladder inflammation exposure to aromatic amines |
| gptkbp:subspecies |
muscle invasive urothelial carcinoma
non-muscle invasive urothelial carcinoma |
| gptkbp:symptom |
hematuria
pelvic pain urinary frequency dysuria |
| gptkbp:synonym |
transitional cell carcinoma
|
| gptkbp:treatment |
surgery
radiation therapy chemotherapy immunotherapy |
| gptkbp:bfsParent |
gptkb:bladder_cancer
gptkb:Keytruda |
| gptkbp:bfsLayer |
5
|